GRMSX
Price
$28.08
Change
+$0.30 (+1.08%)
Updated
Dec 24 closing price
VTSAX
Price
$144.66
Change
+$1.55 (+1.08%)
Updated
Dec 24 closing price
Ad is loading...

GRMSX vs VTSAX

Header iconGRMSX vs VTSAX Comparison
Open Charts GRMSX vs VTSAXBanner chart's image
Nationwide S&P 500 Index Svc
Price$28.08
Change+$0.30 (+1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.66
Change+$1.55 (+1.08%)
VolumeN/A
CapitalizationN/A
GRMSX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRMSX vs. VTSAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRMSX is a StrongBuy and VTSAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.84T vs. GRMSX (1.62B). VTSAX pays higher dividends than GRMSX: VTSAX (1.35) vs GRMSX (0.86). GRMSX was incepted earlier than VTSAX: GRMSX (26 years) vs VTSAX (24 years). GRMSX is a more actively managed with annual turnover of: 5.76 vs. VTSAX (2.00). VTSAX has a lower initial minimum investment than GRMSX: VTSAX (3000) vs GRMSX (25000). GRMSX (25.82) and VTSAX (25.73) have marching annual gain over last year. VTSAX (81.67) and GRMSX (80.99) have equivalent 5 years return.
GRMSXVTSAXGRMSX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years24 years-
Gain YTD25.43325.370100%
Front LoadN/AN/A-
Min. Initial Investment250003000833%
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B1.84T0%
Annual Yield % from dividends0.861.3564%
Returns for 1 year25.8225.73100%
Returns for 3 years27.2624.29112%
Returns for 5 years80.9981.6799%
Returns for 10 years97.62187.5752%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK10.660.40
+3.90%
CleanSpark
STEL28.770.11
+0.38%
Stellar Bancorp
DOW40.090.12
+0.30%
Dow
MG8.77-0.12
-1.35%
Mistras Group
SABS4.10-0.18
-4.21%
SAB Biotherapeutics